What is integrated health screening service in India?

A service that trains health coordinators to screen patients for multiple diseases simultaneously (TB + diabetes + asthma) instead of single-disease screening. The coordinator identifies undiagnosed comorbidities and links patients to treatment at clinics. This fills gaps in India's disease-specific healthcare system, as the Hindu article noted that screening 26,000 people for TB identified 3,000 additional COPD/asthma cases needing care.

How much does it cost to start this service in India?

₹15-25 lakh for MVP stage covering: training health coordinators (₹3-5 lakh), basic digital record system (₹5-8 lakh), first 5-10 coordinators for 3 months (₹4-8 lakh), pilot clinic setup (₹2-3 lakh). Scaling to 20-50 coordinators across 5-10 districts requires ₹50-80 lakh additional capital.

Is this service profitable in India?

Yes. At ₹200-400 per patient screening × 50,000 patients/year + ₹40,000/month per coordinator × 100 coordinators, annual revenue reaches ₹3.6-8 crore with 40-50% gross margins. Government health departments allocate ₹500-1,000 per patient for TB-related care under NRHM; integrated screening fits this budget.

What regulations apply to integrated health screening in India?

National Health Mission (NHM) guidelines govern health worker training and clinic partnerships. Indian Public Health Standards (IPHS) regulate screening protocols. State health department registration required as healthcare service provider. GST 5% applies to health services. Patient data must comply with Health Data Localization rules (stored in India). No specific act prohibits this; it aligns with India's National TB Elimination Programme and diabetes management guidelines.

Integrated Health Screening Service India 2026 — Business

AI SummaryIntegrated health screening is a ₹2,500-4,000 crore annual opportunity in India serving 2.8 million TB patients + 77 million diabetics in tier-2 cities and rural areas. A trained health coordinator who screens for multiple diseases simultaneously can identify 10-15% undiagnosed comorbidities per 100 patients, filling critical gaps in India's disease-specific clinic model. Government health departments under NHM and NRHM budgets actively seek comorbidity identification solutions; pilots in Bihar and Tamil Nadu (mentioned in article) show proven demand. Small healthcare entrepreneurs with ASHA network access can launch this service with ₹15-25 lakh capital and scale to ₹3-8 crore revenue within 3 years.